Healthcare >> Analyst Interviews >> October 17, 2003

Investing In Biotechnology: David Wood – Rodman & Renshaw Inc

DAVID E. WOOD is a Senior Biotechnology Analyst at Rodman & Renshaw. Prior to joining Rodman, Dr. Wood was an analyst in Stephens Inc's. equity research department. He earned his PhD in molecular oncology and immunology studying the molecular mechanism of chemotherapy-induced apoptosis of leukemia cells. In addition, Dr. Wood carried out postdoctoral training at Children's Hospital/Harvard Medical School studying gene expression in Alzheimer's disease. He earned his PhD from New York University School of Medicine and his BA in Biology from Bowdoin College. Profile
TWST: Would you begin with an overview of your coverage?

Mr. Wood: I joined Rodman & Renshaw about three months ago and have been

developing a coverage list that will focus on companies